Patents-Review.com
ClassID:

96548 ⎘

C07J41/005 - CPC Classification

Classification description:

Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives

Recent Application in this class:
#1
20260109731
2026-04-23

NEUROSTEROID DERIVATIVE AND USE THEREOF

 #2
20260053937
2026-02-26

STEROIDS AND PROTEIN-CONJUGATES THEREOF

 #3
20260027131
2026-01-29

PRODRUGS, PRODRUG COMPOSITIONS AND RELATED METHODS

 #4
20250312355
2025-10-09

DHCR24 INHIBITORY COMPOUNDS

 #5
20250092084
2025-03-20

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #6
20250034201
2025-01-30

PRODRUGS OF GANAXOLONE

 #7
20250026781
2025-01-23

Prodrugs of Neurosteroid Analogs and Uses Thereof

 #8
20250002525
2025-01-02

Aminosteroids for the Treatment of a PTP1B Associated Disease

 #9
20240408223
2024-12-12

HYDROPHILIC LINKERS FOR ANTIBODY DRUG CONJUGATES

 #10
20240327452
2024-10-03

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

 #11
20240132536
2024-04-25

CRYSTAL FORM OF 3-HYDROXY-5-PREGNANE-20-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #12
20240101594
2024-03-28

STEROIDS AND PROTEIN-CONJUGATES THEREOF

 #13
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #14
20230357309
2023-11-09

PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THERETO

 #15
20230265121
2023-08-24

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #16
20230203088
2023-06-29

Aminosteroids for the Treatment of a PTP1B Associated Disease

 #17
20230174569
2023-06-08

PROCESS PER PREPARING (3a,5a)-20-OXOPREGNAN-3-YL GLYCYL-L-VALINATE HYDROCHLORIDE

 #18
20230116347
2023-04-13

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #19
20230021308
2023-01-19

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #20
20220402966
2022-12-22

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #21
20220340614
2022-10-27

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #22
20220235092
2022-07-28

PROGESTERONE ANALOGS AND USES RELATED THERETO

 #23
20220204548
2022-06-30

SMALL MOLECULE MODULATORS OF GUT BACTERIAL BILE ACID METABOLISM

 #24
20220162257
2022-05-26

3ALPHA, 5BETA-NEUROACTIVE STEROIDS FOR THE TREATMENT OF EPILEPSY AND SEIZURE DISEASES

 #25
20220153776
2022-05-19

ANTAGONISTS OF CB1 RECEPTOR

 #26
20220017565
2022-01-20

Steroid derivative regulators, method for preparing the same, and uses thereof

 #27
20220002340
2022-01-06

C7, C12, and C16 substituted neuroactive steroids and their methods of use

 #28
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #29
20210395294
2021-12-23

Progesterone phosphate analogs and uses related thereto

 #30
20210332080
2021-10-28

Hydrophilic linkers for antibody drug conjugates

 #31
20210230211
2021-07-29

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #32
20210101928
2021-04-08

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #33
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #34
20210040144
2021-02-11

Steroids and protein-conjugates thereof

 #35
20200317717
2020-10-08

Process for preparation of sulfonyl carbamate bile acid derivatives

 #36
20200270300
2020-08-27

Aminosteroids for the treatment of a PTP1B associated disease

 #37
20200255470
2020-08-13

Progesterone phosphate analogs and uses related thereto

 #38
20200109164
2020-04-09

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #39
20190322698
2019-10-24

WATER-SOLUBLE ALLOPREGNENOLONE DERIVATIVE AND USE THEREOF

 #40
20190284226
2019-09-19

Thionyl tetrafluoride modified compounds and uses

 #41
20190276489
2019-09-12

Progesterone analogs and uses related thereto

 #42
20190248831
2019-08-15

C17, C20, and C21 substituted neuroactive steroids and their methods of use

 #43
20190233465
2019-08-01

C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

 #44
20190202858
2019-07-04

Aminosteroids for the treatment of a PTP1B associated disease

 #45
20190202857
2019-07-04

3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE

 #46
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #47
20190151458
2019-05-23

Lipid-linked prodrugs

 #48
20190071465
2019-03-07

ANTAGONISTS OF CB1 RECEPTOR

 #49
20190010184
2019-01-10

Methods for preparation of bile acids and derivatives thereof

 #50
20190008875
2019-01-10

Steroid alkaloids and compositions and kits thereof

 #51
20180340005
2018-11-29

Conjugated Neuroactive Steroid Compositions And Methods Of Use

 #52
20180327444
2018-11-15

Chemical compounds and use thereof for improving muscular quality

 #53
20180291058
2018-10-11

Process for preparation of sulfonyl carbamate bile acid derivatives

 #54
20180237471
2018-08-23

Bile acid derivatives as FXR agonists and methods of use thereof

 #55
20180221279
2018-08-09

MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES

 #56
20180194798
2018-07-12

Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof

 #57
20180155389
2018-06-07

Steroids and protein-conjugates thereof

 #58
20180094018
2018-04-05

Progesterone phosphate analogs and uses related thereto

 #59
20170369522
2017-12-28

3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

 #60
20170266206
2017-09-21

Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport

 #61
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #62
20170226151
2017-08-10

Chemical compounds and use thereof for improving muscular quality

 #63
20170022245
2017-01-26

GANAXOLONE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEMS DISORDERS

 #64
20160317556
2016-11-03

ATP synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteria

 #65
20160289262
2016-10-06

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

 #66
20160272670
2016-09-22

STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION

 #67
20160272662
2016-09-22

General catalyst for C-H functionalization

 #68
20160194351
2016-07-07

Progesterone phosphate analogs and uses related thereto

 #69
20160159852
2016-06-09

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

 #70
20160145294
2016-05-26

Antagonists of CB1 receptor

 #71
20160052957
2016-02-25

Progesterone analogs and uses related thereto

 #72
20160009752
2016-01-14

PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS

 #73
20150284423
2015-10-08

3-(4′-substituted)-benzyl-ether derivatives of pregnenolone

 #74
20150105547
2015-04-16

NITRIC OXIDE RELEASING STEROIDS

 #75
20150099727
2015-04-09

Aminosteroids for the treatment of a PTP1B associated disease

 #76
20140378399
2014-12-25

Vascular leakage inhibitor

 #77
20140356417
2014-12-04

Modified drugs for use in liposomal nanoparticles

 #78
20140200200
2014-07-17

Antagonists of CB1 receptor

 #79
20140148593
2014-05-29

Process for preparing fluticasone propionate/furoate

 #80
20140018312
2014-01-16

Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria

 #81
20140011793
2014-01-09

NEW STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM, AND METHODS FOR THEIR PRODUCTION

 #82
20140011792
2014-01-09

STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION

 #83
20140011779
2014-01-09

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #84
20140005132
2014-01-02

Contraceptive agents

 #85
20130303499
2013-11-14

Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology

 #86
20130281421
2013-10-24

Steroids having increased water solubility and resistance against metabolism and methods for their production

 #87
20130266645
2013-10-10

Derivatives of steroid benzylamines, having an antiparasitic antibacterial, antimycotic and/or antiviral action

 #88
20130210785
2013-08-15

PROGESTERONE ANALOGS AND USES RELATED THERETO

 #89
20130102577
2013-04-25

Ship inhibitors and uses thereof

 #90
20120237591
2012-09-20

Modified drugs for use in liposomal nanoparticles

 #91
20120214872
2012-08-23

Bile acid or bile salt fatty acid conjugates

 #92
20120071453
2012-03-22

Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them

 #93
20110294769
2011-12-01

NITROOXY DERIVATIVES OF GLUCOCORTICOIDS

 #94
20110263526
2011-10-27

Nitric Oxide Releasing Prodrugs of Therapeutic Agents

 #95
20110165225
2011-07-07

Modified drugs for use in liposomal nanoparticles

 #96
20110144073
2011-06-16

Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology

 #97
20110130376
2011-06-02

NEW NO RELEASING STEROIDS DERIVATIVES

 #98
20110091376
2011-04-21

Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods

 #99
20110028440
2011-02-03

Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine

 #100
20100324004
2010-12-23

Method for treating diabetes

 #101
20100261691
2010-10-14

AMORPHOUS FORM OF AN ANTI-INFLAMMATORY COMPOUND

 #102
20100234334
2010-09-16

NITRIC OXIDE RELEASING STEROIDS

 #103
20100093685
2010-04-15

Nitric oxide releasing steroids

 #104
20100041633
2010-02-18

NITRIC OXIDE RELEASING STEROIDS

 #105
20090264394
2009-10-22

NITROOXY DERIVATIVES OF GLUCOCORTICOIDS

 #106
20090264393
2009-10-22

NITROOXY DERIVATIVES OF GLUCOCORTICOIDS

 #107
20090258849
2009-10-15

NITROOXY DERIVATIVES OF GLUCOCORTICOIDS

 #108
20090221543
2009-09-03

NEW CORTICOSTEROIDS

 #109
20090082314
2009-03-26

Targeting Prodrugs for the Treatment of Gastrointestinal Diseases

 #110
20090023896
2009-01-22

COMPOUNDS WITH A SULPHONAMIDE GROUP AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS

 #111
20080234242
2008-09-25

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #112
20080221073
2008-09-11

Nitrooxy Derivatives of Glucocorticoids

 #113
20080119416
2008-05-22

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #114
20070161612
2007-07-12

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #115
20070142342
2007-06-21

Nitrooxyderivative steroidal compounds

 #116
20060270644
2006-11-30

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #117
20060160781
2006-07-20

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #118
20060160780
2006-07-20

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #119
20060154905
2006-07-13

Nitrate esters of corticoid compounds and pharmaceutical applications thereof

 #120
20060063746
2006-03-23

17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators

 #121
20060052594
2006-03-09

New corticosteroids

 #122
20050176694
2005-08-11

Steroidal compounds

 #123
20050026068
2005-02-03

Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties

 #124
20050004089
2005-01-06

Nitrate esters of corticoid compounds and pharmaceutical applications thereof